Department of Otorhinolaryngology-Head and Neck Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, United States.
Department of Otolaryngology-Head and Neck Surgery, The University of Iowa Hospitals and Clinics, Iowa City, IA, United States.
Auris Nasus Larynx. 2023 Apr;50(2):292-298. doi: 10.1016/j.anl.2022.08.002. Epub 2022 Aug 4.
To identify differences in inpatient otolaryngology consultations and interventions for patients based on COVID-19.
Records were reviewed for all patients for whom otolaryngology was consulted at a high-volume tertiary care hospital from April 30, 2020 to October 1, 2020. Demographic information, length of stay, COVID-19 status, indication for consultation, and otolaryngology interventions were recorded. Statistical analysis was performed using R software.
Bleeding composed a significantly higher proportion of otolaryngology consults in COVID-19 positive patients (28% vs. 8.4%, p<0.0001). Management of bleeding was the most common procedure performed in positive patients (n=37, 35%), and they had a higher median number of interventions performed when compared to bleeding patients who tested negative (1, IQR 1-2 vs. 1, IQR 0-1, p=0.04). COVID-19 positive patients with bleeding were more likely to expire than those with other indications for otolaryngology consultation (50% vs. 7%, p<0.001).
Bleeding and associated interventions comprised the predominant discrepancy between COVID-19 positive and negative patients in our cohort. We encourage routine use of simple and cost-effective methods to decrease risk of bleeding.
确定 COVID-19 患者住院耳鼻喉科会诊和干预的差异。
回顾 2020 年 4 月 30 日至 10 月 1 日在一家高容量三级保健医院接受耳鼻喉科会诊的所有患者的记录。记录人口统计学信息、住院时间、COVID-19 状态、会诊指征和耳鼻喉科干预措施。使用 R 软件进行统计分析。
COVID-19 阳性患者中耳鼻喉科会诊的出血构成比例明显更高（28%比 8.4%，p<0.0001）。在阳性患者中，出血的治疗是最常见的操作（n=37，35%），与 COVID-19 阴性患者相比，他们进行的干预措施中位数更多（1，IQR 1-2 与 1，IQR 0-1，p=0.04）。COVID-19 阳性伴出血患者的死亡率高于其他耳鼻喉科会诊指征患者（50%比 7%，p<0.001）。
在我们的队列中，COVID-19 阳性和阴性患者之间主要的差异是出血和相关干预。我们鼓励常规使用简单且具有成本效益的方法来降低出血风险。
